Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Cancer. 2010 Apr 1;116(7):1810–1819. doi: 10.1002/cncr.24954

Table 3.

Baseline Characteristics Associated with Advanced Cancer Patient Having Anxiety Disorder

Measure Full Sample
(N=635)
Patients With
Anxiety Disorders
(N=48)
Patients Without
Anxiety Disorders
(N=587)
Unadjusted
Analyses
Adjusted
Analyses
N (%) N (%) N (%) O.R. p-value O.R. p-value
Treatment with anxiolytics 36 (5.70) 5 (10.4) 31 (5.10) 2.07 0.15 1.44 0.53
Terminal Illness Acknowledgement 204 (34.6) 19 (42.2) 185 (33.9) 1.42 0.26 1.27 0.49
Treatment Preferences
    Preference for chemotherapy 327 (52.6) 27 (56.3) 300 (52.3) 1.17 0.60 1.18 0.61
    Preference for antibiotics 287 (46.9) 23 (47.9) 264 (46.8) 1.05 0.88 0.96 0.89
    Preference for feeding tube 216 (36.1) 22 (50.0) 194 (35.0) 1.86 0.05 1.58 0.18
    Preference for respirator 160 (25.6) 16 (33.3) 144 (25.0) 1.50 0.21 1.34 0.40
    Preference for any type of
    advanced treatment
448 (71.0) 34 (70.8) 414 (71.0) 0.99 0.98 0.91 0.78
    Extend Life Versus Relieve Pain 165 (28.8) 17 (40.5) 148 (27.8) 1.77 0.08 1.57 0.21
    Heroic Measures 129 (20.8)   9 (18.8) 120 (21.0) 0.87 0.71 0.62 0.26
Advance Care Planning
    DNR 242 (38.8) 17 (35.4) 225 (39.1) 0.86 0.62 0.78 0.45
    Living will 335 (53.9) 22 (45.8) 313 (54.5) 0.71 0.25 0.85 0.62
    Health Care Proxy and/or Durable
    Power of Attorney
339 (54.5) 24 (50.0) 315 (54.9) 0.82 0.52 0.96 0.90

Note: Bolded p-values represent significant differences between patients with and without anxiety disorders.

Adjusted Analyses control for age, gender and karnofsky performance score; Missing Data: Anxiolytics (3), Terminal Illness Acknowledgement (45), Chemotherapy Preference (13), Antibiotics Preference (23), Feeding Tube Preference (37), Respirator Preference (11), Any Aggressive Preference (74), Life Extension (61), Heroic Measures (16), DNR (11), Living Will (13), Health Care Proxy (13)